Investors Asset Management Of Georgia Inc Avadel Pharmaceuticals PLC Transaction History
Investors Asset Management Of Georgia Inc
- $208 Million
- Q1 2024
A detailed history of Investors Asset Management Of Georgia Inc transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 87,375 shares of AVDL stock, worth $1.27 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
87,375
Previous 106,475
17.94%
Holding current value
$1.27 Million
Previous $1.5 Million
1.86%
% of portfolio
0.71%
Previous 0.77%
Shares
25 transactions
Others Institutions Holding AVDL
# of Institutions
132Shares Held
68.4MCall Options Held
1.01MPut Options Held
2.03M-
Janus Henderson Group PLC London, X012.9MShares$188 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY8.8MShares$128 Million2.38% of portfolio
-
Polar Capital Holdings PLC London, X06.75MShares$98.1 Million0.71% of portfolio
-
Gendell Jeffrey L Greenwich, CT5.71MShares$82.9 Million3.76% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.97MShares$57.7 Million8.97% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $880M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...